These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14598513)

  • 1. [Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention].
    Grinenko AIa; Krupitskiĭ EM; Zvartau EE
    Vestn Ross Akad Med Nauk; 2003; (10):54-6. PubMed ID: 14598513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].
    Krupitskiĭ EM; Zvartau EE; Tsoĭ-Podosenin MV; Masalov DV; Burakov AM; Egorova VIu; Didenko TIu; Romanova TN; Ivanova EB; Bespalov AIu; Verbitskaia EV; Neznanov NG; Grineneko AIa; O'Brien C; Woody D
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 2):44-54. PubMed ID: 21322147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
    Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
    Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
    Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
    J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.
    Bisaga A; Sullivan MA; Cheng WY; Carpenter KM; Mariani JJ; Levin FR; Raby WN; Nunes EV
    Drug Alcohol Depend; 2011 Dec; 119(1-2):e23-9. PubMed ID: 21715107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
    Farren CK; Scimeca M; Wu R; Malley SO
    Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.
    Kranzler HR; Modesto-Lowe V; Van Kirk J
    Neuropsychopharmacology; 2000 May; 22(5):493-503. PubMed ID: 10731624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.
    Bisaga A; Sullivan MA; Glass A; Mishlen K; Carpenter KM; Mariani JJ; Levin FR; Nunes EV
    J Subst Abuse Treat; 2014; 46(5):546-52. PubMed ID: 24560438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence.
    Farren CK; O'Malley S
    Am J Addict; 2002; 11(3):228-34. PubMed ID: 12202015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.
    Hulse GK; Ngo HT; Tait RJ
    Biol Psychiatry; 2010 Aug; 68(3):296-302. PubMed ID: 20537615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.
    Wang AL; Elman I; Lowen SB; Blady SJ; Lynch KG; Hyatt JM; O'Brien CP; Langleben DD
    Transl Psychiatry; 2015 Mar; 5(3):e531. PubMed ID: 25781230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression].
    Bun'kova KM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):29-32. PubMed ID: 18427538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haight-Ashbury free clinics' drug detoxification protocols--Part 2: Opioid blockade.
    Galloway G; Hayner G
    J Psychoactive Drugs; 1993; 25(3):251-2. PubMed ID: 8258763
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK; Morris N; Arnold-Reed D; Tait RJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Depression in alcohol addicted patients].
    Ponizovskiy PA; Gofman AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
    Landabaso MA; Iraurgi I; Jiménez-Lerma JM; Sanz J; Fernádez de Corres B; Araluce K; Calle R; Gutiérrez-Fraile M
    Addiction; 1998 May; 93(5):739-44. PubMed ID: 9692272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.